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IgA synthesis by lymphocytes from patients with IgA nephropathy and
their relatives. To investigate the hypothesis that a predisposition to IgA
nephropathy (IgAN) is linked to the major histocompatibility complex
(MHC) and associated with poorly regulated IgA synthesis, we per-
formed HLA typing and lymphocyte cultures on patients with IgAN
and their relatives. Ninetten of 22 patients had elevated culture super-
natant IgA concentrations (620 vs. 154 ng/2 x 106 cells, P = 0.007).
Supernatent IgG and 1gM were normal. No HLA antigen occurred with
increased frequency in patients. There was an increased incidence of
homozygous null C4 alleles in patients (P < 0.01). In families, six of 11
mothers, six of 12 fathers, and seven of 15 siblings had elevated
supernatant IgA concentrations. There was no segregation of abnormal
IgA production with any HLA antigen or parental haplotype. The data
confirm elevated in vitro IgA production by lymphocytes from patients
with IgAN, but do not support a linkage with the MHC. The increased
incidence of homozygous null C4 alleles may result from functional
differences in C4 A and B gene products. The familial clustering of
elevated IgA production without an obvious inheritance pattern suggest
that shared environmental factors may be important in the development
of IgAN.
IgA deposition in the renal mesangium is associated with
systemic diseases such as systemic lupus erythematosus, sub-
acute bacterial endocarditis, chronic cirrhosis and Henoch—
Schonlein purpura (HSP), but also occurs in the absence of any
systemic symptoms. Berger and Hinglais first described a
primary glomerulonephritis associated with IgA deposition in
1968 [1]. Their patients had a focal proliferative glomerulone-
phritis associated with diffuse mesangial immunofluorescence
for IgA, IgG and C3. Subsequent work has demonstrated
diffuse mesangial, paramesangial and occasional empimembra-
nous immune deposits [2]. Clinically these patients have recur-
rent gross, and persistent microscopic, hematuria. Although
renal function is initially normal, long—term follow—up suggests
that up to 30% of patients may progress to end—stage renal
disease (ESRD) over 10 to 20 years [3]. Despite many attractive
theories, the precise etiology of IgA nephropathy remains
unknown, and no effective therapy has been described [4].
A variety of interesting laboratory abnormalities have been
identified in patients with IgA nephropathy. Serum IgA levels
are elevated in approximately 30%, and IgA containing circu-
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lating immune complexes are frequently detected [5, 6]. Several
investigators have demonstrated elevated in vitro IgA produc-
tion by cultured mononuclear cells [7—9]. It appears that this
elevated production is the result of both in vivo B cell activation
and a selective deficiency of IgA-specific T suppressor cells.
Some investigators have identified increased numbers of IgA-
bearing peripheral blood and tonsillar lymphocytes [10, 11]. The
disease has also been associated with different HLA antigens in
different populations [12, 15]. These associations are proposed
to be related to immune response genes coded within or near
the HLA-D region. Sporadic reports of familial cases of IgA
nephropathy have also appeared [16—19].
From these observations, we proposed that individuals (oc-
casionally related) would be predisposed to develop IgA neph-
ropathy if they inherited certain HLA antigens which might be
associated with elevated in vivo (and in vitro) IgA production.
To investigate this hypothesis, HLA typing, C4 allotyping and
mononuclear cell cultures were performed on patients with IgA
nephropathy and their first degree family members.
Methods
Patients
Twenty-seven patients, followed at the Children's Hospital
Medical Center, Cincinnati, Ohio, had a diagnosis of primary
IgA nephropathy confirmed by renal biopsy. Secondary forms
of IgA nephropathy were excluded. The patients ranged in age
from four to 21 years (mean = 13.4). The patients were white
except for one black male. There were 19 boys and eight girls.
No patient was significantly azotemic (serum creatinine >1.5
mg/dliter) at the time of study. One patient had received a renal
allograft and was receiving alternate day prednisone (approxi-
mately 1 mg/kg) at the time of study. This patient had a rapidly
progressive course of IgA nephropathy and no clinical evidence
of recurrence at the time of culture. Twenty—two patients had
cell culture studies and HLA typing performed. C4 allotyping
was performed on all 27 patients.
Eleven mothers, 12 fathers, and 15 siblings (II boys and 4
girls) of the patients were studied. All relatives were well at the
time of study with normal urinalyses. Writen informed consent
was obtained from parent, patients or family members as
appropriate.
1229
1230 Waldo et a!
Mononuclear cell separation and culture
Heparinized whole blood was obtained sterilely and the
mononuclear cell fraction separated by centrifugation on ficoll
hypaque. The cells were harvested, washed three times in
Hank's balanced salt solution (HBSS, Gibco, Grand Island,
New York, USA) and centrifuged through heat inactivated fetal
calf serum (FCS, Gibco) to remove any passively absorbed
immunoglobulin. Cells were adjusted to a concentration of 2 x
106/mliter in RPM! 1640 (Gibco) with 15% FCS, 10,000 units!
mliter penicillin and 10 g/mliter streptomycin added. Cells
were cultured at a density of 4 x 106 cells/2 mliter in 24 well
microtiter plates (Costar, Boston, Massachusetts, USA) in a
humidified 5% CO2 incubator at 37°C for 12 days. The cell
viability was determined by trypan blue dye exclusion. Only
supernatants from uncontaminated cultures with greater than
90% cell viability were used. Cyclohexamide l0- M was added
to four cultures and caused 80 to 100% suppression of immu-
noglobulin production. Cell free supernatants were stored at
—20°C until assayed.
Immunoglobulin measurement: IgG and IgA in the cultured
supernatants were measured using a solid phase immuno-
fluorescent assay, !mmunoflor (Bio—Rad, Richmond, Califor-
nia, USA). The manufacturer's instructions were followed
except for a modification to permit extremely low level !gA and
IgG measurements. The standards were first diluted as directed
and then further diluted 1:5 before use in the assay. The diluted
standard at 0.5 mliter or 0.5 mliter undiluted culture supernatant
was mixed with a 1 mliter suspension of "!mmunobeads"
conjugated with either anti-!gA or anti-IgG. The procedure was
then completed according to manufacturer's instructions. Lin-
ear standard curves from 165 to 1,145 nglmliter for IgA, and 166
to 1,152 ng/mliter for lgG were obtained and unknown concen-
trations determined from these. Supernatants which exceeded
the standard range were diluted and rerun.
1gM was measured by an ELISA technique. Briefly, anti-
human 1gM was raised in goats, the serum absorbed to mono-
specificity, and an Ig fraction obtained by octonoic acid precip-
itation [20]. the Ig fraction was affinity purified and biotinylated
as previously described [211. Polysytrene microtiter plates
(Limbro, McLean, Virginia, USA) were coated overnight at 4°C
with 0.1 mliter of affinity purified anti-human 1gM at 10 g/
mliter in 0.06 M pH 9 carbonate buffer. The wells were then
blocked for 30 mm at 37°C with 0.2% bovine serum albumin in
carbonate buffer. Wells were washed with PBS. 0.01 NI EDTA,
and 0.05% Tween 20 (wash buffer), and 0.1 mliter aliquots of
undiluted culture supernatants or 1gM standards were added. A
curve was constructed from a calibrator serum of known 1gM
concentration serially diluted in culture media, and incubated
for one hour at 37°C. The wells were washed and then incubated
for two hr at 37°C with 0.1 mliter of a 1:800 dilution of
biotinylated, affinity purified anti-human 1gM. After washing,
0.1 mliter of avidin—peroxidase (Sigma, St. Louis, Missouri,
USA) was added for 30 mm at room temperature, and the wells
were then washed and developed with o-phenylenediamine
(Sigma). A log linear curve from 50 to 1000 ng!mliter was
obtained and unknowns determined from this. Values from
wells coated with RPM! 1640, 15% FCS were not significantly
different from those coated with wash buffer alone.
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Fig. 1. Unfractionated mononuclear cell culture production of immu-
noglobulin; isolated mononuclear cells were cultured for 12 days and
the supernalan! concentrations of IgA (P = 0.007), JgG (P = 0.05) and
1gM (P = 0.05) determined. Twenty—eight healthy controls and 22
patients with IgA nephropathy were studied. Data are expressed as
means 2 SD (illustrated by lines) for controls and as mean values for
patients.
HLA and C4 typing
HLA typing was performed by the clinical laboratory at
Hoxworth Blood Bank, Cincinnati, Ohio. C4 aflotyping was
performed by the method of Awdeh and Alper [22]. Serum
immunoglobulin measurements were performed using an Auto
ICS nephelometer (Beckman, Laiolla, California, USA).
Statistics. Statistical comparisons were made using the chi
squared test, analysis of variance, and multiple linear regression.
Results
Mononuclear cell cultures fr immunoglobulin production
Unfractionated mononuclear cell preparations were from 30
healthy controls. Eight children (ages two to 20, mean = 11
years) and 22 adults (ages 26 to 59, mean = 35) were cultured
for 12 days in the absence of mitogenic stimulation. The mean
supernatant concentrations of lgA, lgG. and 1gM were 154,
1181, and 142 ng/2 x 106 cells respectively (Fig. 1). There was
no overall relationship between age and supernatant !gA con-
centration (r 0.32, P > 0.05). Mean supernatant !gA in the
children was 165 ng/2 x 106 cells, and for the adults, 149 ng/2 x
106 cells (P > 0.05). Kinetic analysis of !gA production was
performed on four separate individuals. There was a plateau of
net immunoglobulin production at eight to ten days regardless
of the final value. Four individuals had repeat cultures during an
episode of upper respiratory or gastrointestinal infection and
the net production of all immunoglobulin classes remained
within the normal range.
Mononuclear cell cultures in patients with IgA nephropathy
As illustrated in Figure 1, mononuclear cells were isolated
from 22 patients with IgA nephropathy. Nineteen of 22 patients
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with IgA nephropathy had supernatant IgA concentrations
greater than two SD above the mean of control. The mean
patient supernatant IgA concentration was 620 compared to the
control of 133 ng/2 x 106 cells (P = 0.007). Supernatant
concentrations of IgG and 1gM were elevated in seven and three
patients with IgA nephropathy, respectively. However, the
mean supernatant IgG and 1gM concentrations in patients were
not significantly different from controls (P > 0.05).
One of the IgA nephropathy patients with a normal superna-
tant IgA concentration had a renal allograft. The two other
patients with IgA nephropathy and normal supernatant IgA
concentration could not be distinguished from the entire patient
group in any other way. In particular, there was no difference in
their duration of disease, frequency of gross hematuria, quali-
tative degree of proteinuria or serum creatinine level.
Serum IgA was elevated for age in II of 22 patients with IgA
nephropathy. There was no correlation between the serum level
of IgA and the supernatant IgA concentrations (r = 0,29, P >
0.05). Eight patients had significantly elevated supernatant IgA
concentrations but normal serum IgA levels.
HLA and C4 allotyping
HLA typing was performed on 27 patients with IgA nephrop-
athy, and no antigen was present in significantly increased
frequency. In particular, B12, Bw35, and DR4, antigens previ-
ously associated with IgA nephropathy, were observed at
frequencies of 0.23, 0,2 and 0.4, respectively, with expected
frequencies of 0.28, 0.15 and 0.28 (uncorrected P > 0.1). C4 is
coded within the HLA complex at 4 alleles (two A and two B).
Awdeh et al have defined "extended" HLA haplotypes by
allotyping C4, C2, factor B and glyoxalase [23]. Patients with
IgA nephropathy have been reported to have an increased
incidence of C4 null genes at either the A or B locus [24]. No
extended haplotype has been reported in increased incidence in
IgA nephropathy [25]. Homozygous null C4B genes were found
in five of 27 patients. This differs significantly from the observed
incidence in the Cincinnati area of 3 out of 75 (x2 = 5.47, P <
0.01) [26]. Homozygous null B genes have reported to occur in
the extended haplotype B12, DR4, B5, C2 C, C4 A3, C4BqO.
Based on HLA and C4 typing alone, two of our patients may
have had this haplotype. This incidence of two out of 27
patients would not differ from the observed frequency in the
Boston area of 10 out of 295 (x2 = I.!).
Family studies
Immunoglobulin production by mononuclear cells from first
degree relatives of patients with IgA nephropathy was mea-
sured. As illustrated in Figure 2, there was elevated supernatant
IgA concentrations in six of 11 mothers, six of 12 fathers and
seven of 15 siblings. No significant increase in the concentra-
tions of IgG or 1gM in supernatants was observed (not shown).
Elevated parental IgA production varied; four families had one
parent affected, three had both, and four had neither parent
affected. HLA typing was performed on three complete fami-
lies. The H family had two affected members, one with typical
IgA nephropathy and the other with typical HSP. In this family,
elevated IgA was present in the father and several siblings but
not in the mother. The segregation of elevated immunoglobulin
production in siblings followed no HLA antigen or parental
haplotype. In the L family, all members had elevated IgA
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Fig. 2. Unfractionated mononuclear cell culture production of IgA in
first degree relatives of patients with IgA nephropathy.
production whereas in the W family, IgA production was
elevated only in the parents. Thus, no correlation between an
HLA antigen or parental haplotype and increased IgA produc-
tion could be made.
Discussion
Studies of in vitro immunoglobulin production by mononu-
clear cells from patients with IgA nephropathy have suggested
abnormal immunoregulation of IgA synthesis. Studies by others
using slightly different techniques have yielded similar, but not
identical, results to those of Cosio and Beale [9, 27, 28]. Beale
et al studied patients with HSP, an IgA related renal disease,
and found increased spontaneous (non-mitogen stimulated)
production of IgA by unfractionated mononuclear cells [7]. B
cells isolated from these patients, in the absence of T cells
produced significant amounts of IgA, suggesting that in vivo B
cell activation had occurred. Allogenic mixing experiments
suggested that defective T suppressor cell activity was also
present. Cosio et al studied patients with IgA nephropathy and
demonstrated increased spontaneous production of IgA by
unfractionated mononuclear cells [8].
Previous studies have also identified significant associations
between IgA nephropathy and HLA Bw35 in France and
Australia, HLA DR4 in France and Japan, and HLA B12 in
Florida [12—15]. No association with any HLA antigen, how-
ever, was identified in a group of patients from the United
Kingdom [29]. An increased incidence of homozygous null A or
B genes for the fourth component of complement, which lies
within the major histocompatibility complex (MHC), has also
been reported in patients with IgA nephropathy, or HSP [24].
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Furthermore, a number of families in which more than one
member have IgA nephropathy have been reported in one of
these, the asymptomatic brother of a patient with the disease
was found to have glomerular IgA deposits [12, 16—19]. Prelim-
inary evidence of elevated IgA synthesis by cultured lympho-
cytes from family members has also appeared [30]. Recently a
large kindred from Western Kentucky has been reported [31].
This kindred had an unusually high incidence of IgA nephrop-
athy, was not excessively inbred, and pedigree analysis sug-
gested an autosomal dominant inheritance mode with poor
penetrance.
From these observations, we proposed that a gene in or near
the MHC conferred a predisposition to IgA nephropathy, and
was associated with abnormal immunoregulation and elevated
in vitro IgA production. Any HLA allotype in linkage dis-
equilibrium with this proposed gene would occur with increased
frequency in patients with IgA nephropathy. Furthermore,
healthy first degree relatives having this HLA allotype would
also have the abnormal immunoregulatory gene and elevated in
vitro IgA production.
Unfractionated mononuclear cells from our patients with IgA
nephropathy cultured without mitogenic stimulation produced
significantly more IgA than controls, confirming the presence of
abnormal immunoregulation in patients with IgA nephropathy.
Interestingly, no significant correlation was found between the
serum level of IgA and the quantity of IgA produced in cell
culture. The serum concentration of IgA is determined not only
by its rate of synthesis, but by its rate of clearance, which could
be elevated in patients with IgA nephropathy. Furthermore, the
rate of in vitro synthesis does not necessarily reflect that which
occurs in vivo.
In our patients with IgA nephropathy, contrary to previous
results, no HLA antigen was observed in increased frequency.
However, there was an increased incidence of homozygous null
B genes for C4. The reason for disease associations with the
MHC are unclear. Awdeh have established extended haplo-
types within the MHC defined by HLA typing, combined with
C2, C4, B and glyoxalase typing [23]. These extended haplo-
types are conserved in a population by crossover suppression
and male transmission bias. It has been proposed that disease
susceptibile genes within this complex are also conserved and
help maintain linkage between diseases and the HLA antigens.
However, the extended haplotype containing homozygous null
B alleles was not observed at an increased incidence in patients,
making this explanation unlikely in the present series.
The association between C4 B null alleles and IgA nephrop-
athy may result instead from the difference in hemolytic activity
of C4, A and B gene products. Most of the hemolytic C4 activity
resides in C4, B gene products. Patients who are null at both
C4, B loci have relatively low hemolytic C4 levels [26]. The
classical pathway of complement should be important in the
processing and clearance of IgA-lgG immune complexes. A
relative deficiency in C4 hemolytic activity could, thus, be one
of several predisposing factors in the development of IgAN.
The above data confirm the association between elevated in
vitro production of IgA and nephropathy, but provide no
evidence to link elevated in vitro IgA production with a
particular HLA antigen. Abnormal IgA immunoregulation
could, however, be inherited at a locus not linked to the MHC
and, thus, occur within families. Family studies were done to
pursue this possibility. Mononuclear cells obtained from ap-
proximately half of the parents and siblings of patients with IgA
nephropathy produced abnormally large amounts of IgA in
culture. However, no clear Mendelian pattern of inheritance
was observed. Families were observed with one, both or
neither parent involved. Three kinships had complete HLA
typing, and elevated IgA production did not segregate with any
measured HLA haplotype. The data clearly indicate familial
clustering of elevated IgA production, but point to no simple
pattern of inheritance.
Although elevated IgA production is associated with IgA
nephropathy, its pathogenetic importance remains unclear.
Elevated IgA production alone would seem inadequate to
produce disease since half the family members studied had this
phenotype while reported familial cases of IgA nephropathy
were relatively rare. It is possible that healthy family members
with elevated IgA production actually have occult IgA nephrop-
athy and would have positive mesangial immunofluorescence
for IgA if biopsied. Such a case of occult IgA nephropathy has
been previously described [12]. Until a reliable, non-invasive
marker of IgA nephropathy is established this question will
remain unanswered.
Since the data do not establish a genetic pattern for the
observed familial clustering of elevated IgA production, the
possibility of environmental factors must be considered. Viral
agents, such as Epstein—Barr virus and other members of the
herpes family, are well known B cell mitogens and could served
as shared environmental exposures. Dietary substances such as
bacterial lipopolysaccharide could also act as local mitogens for
T-helper/inducer cells in the gut associated lymphoid tissue.
Studies of unrelated individuals living in the same household as
those patients with IgA nephropathy could help clarify this
issue. Finally, it will be important to determine if the same
cellular mechanisms are responsible for elevated IgA produc-
tion in patients and their family members.
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